Literature DB >> 1838969

An immunological study in patients with seborrhoeic dermatitis.

I M Bergbrant1, S Johansson, D Robbins, A Scheynius, J Faergemann, T Söderström.   

Abstract

The humoral and cellular immune-status was studied in 30 patients with seborrhoeic dermatitis. Increased frequencies of natural killer cells were found in 46% of patients. Furthermore, subnormal mitogen stimulation responses were demonstrated in 13 patients, whereas two individuals were found to have very high numbers of activated T lymphocytes in peripheral blood. Higher-than-normal total serum IgG and IgA was observed in 14 and 11 patients, respectively. For nine of 12 patients with skin lesions, dermal perivascular cell infiltrates were seen. The majority of the infiltrating cells reacted with anti-CD4 antibodies. HLA-DR-expressing keratinocytes were found in two biopsies. The study suggests that patients with seborrhoeic dermatitis may have depressed T-cell function. This could have a bearing on their susceptibility to the Pityrosporum ovale-associated dermatitis. The very high frequencies of activated T cells observed in the peripheral blood of two otherwise healthy seborrhoeic individuals suggests that intermittent systemic immune activation may occur. Seborrhoeic dermatitis is a common skin disease. It can be diagnosed by its characteristic red to yellow-brown lesions covered with greasy scales distributed in areas with a high number of sebaceous glands, such as the scalp, face and upper trunk. There is an association between seborrhoeic dermatitis and the lipophilic yeast Pityrosporum ovale but its exact aetiological role is not known. The yeast is a member of the normal cutaneous flora but also the aetiological agent of pityriasis versicolor and Pityrosporum folliculitis. P. ovale can activate complement via the direct and alternative pathways. This may play some part in the induction of inflammation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838969     DOI: 10.1111/j.1365-2230.1991.tb00395.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

Review 1.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Humoral immune response to Malassezia furfur in patients with pityriasis versicolor and seborrheic dermatitis.

Authors:  V Silva; O Fischman; Z P de Camargo
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 3.  Surface lipids as multifunctional mediators of skin responses to environmental stimuli.

Authors:  Chiara De Luca; Giuseppe Valacchi
Journal:  Mediators Inflamm       Date:  2010-10-20       Impact factor: 4.711

Review 4.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Implication of Perifollicular Clusters and Folliculotropic Distribution of Dendritic Cells in the Pathogenesis of Seborrhoeic Dermatitis.

Authors:  Ayako Ito; Kazunari Sugita; Hiroyuki Goto; Osamu Yamamoto
Journal:  Acta Derm Venereol       Date:  2020-06-15       Impact factor: 3.875

6.  Childhood indicators of susceptibility to subsequent cervical cancer.

Authors:  S M Montgomery; A G C Ehlin; P Sparén; B Björkstén; A Ekbom
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

7.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

8.  Seborrheic Dermatitis and Dandruff: A Comprehensive Review.

Authors:  Luis J Borda; Tongyu C Wikramanayake
Journal:  J Clin Investig Dermatol       Date:  2015-12-15

Review 9.  The Enigma of Bioactivity and Toxicity of Botanical Oils for Skin Care.

Authors:  Erin M Moore; Charles Wagner; Slavko Komarnytsky
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.